MRD tests based on IKZF1-deletions were of particular interest since these deletions occurred in 23% of relapsed B-ALL [29] as well as Ph-like ALL and approximately half are recurrent and can be detected in multiple patients by generic assays [19, 20]. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.